ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 135 filers reported holding ANI PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393,440 | +7.9% | 24,000 | 0.0% | 0.50% | +13.7% |
| Q2 2023 | $1,291,920 | +35.5% | 24,000 | 0.0% | 0.44% | +33.3% |
| Q1 2023 | $953,280 | -1.3% | 24,000 | 0.0% | 0.33% | -14.6% |
| Q4 2022 | $965,520 | +35.6% | 24,000 | 0.0% | 0.39% | +39.8% |
| Q3 2022 | $712,000 | 0.0% | 24,000 | 0.0% | 0.28% | 0.0% |
| Q2 2022 | $712,000 | +5.5% | 24,000 | 0.0% | 0.28% | +18.7% |
| Q1 2022 | $675,000 | -22.9% | 24,000 | +26.3% | 0.24% | -16.4% |
| Q4 2021 | $876,000 | +40.4% | 19,000 | 0.0% | 0.28% | +38.4% |
| Q3 2021 | $624,000 | -6.2% | 19,000 | 0.0% | 0.20% | -8.1% |
| Q2 2021 | $665,000 | -3.2% | 19,000 | 0.0% | 0.22% | -9.8% |
| Q1 2021 | $687,000 | +57.6% | 19,000 | +26.7% | 0.24% | +28.9% |
| Q4 2020 | $436,000 | +54.6% | 15,000 | +50.0% | 0.19% | +36.7% |
| Q3 2020 | $282,000 | – | 10,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |